Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More56 - 60 of 153 results
Recent investment in the sterile fill/finish capabilities at Quotient Sciences' Alnwick, UK facility adds to the current capacity of the Annex 1 compliant facility to meet increasing industry demand for fully integrated drug development pro...
Learn more
Quotient Sciences is one of the 2023 winners of the SME British Made Awards. The company was recognized as the Most Innovative Tailored Drug Development Company in this year's awards.The awards are given solely on merit and are awarded...
Learn more
In a conversation with Outsourcing Pharma at CPHI Barcelona, Paul Quigley, principal research fellow of drug substance at Quotient Sciences, explained how continuous flow manufacturing is taking off in the production of active pharmaceutica...
Learn more
Quotient Sciences announces the appointment of Thierry Van Nieuwenhove as its new Chief Executive Officer (CEO), effective 16th October 2023. Thierry succeeds Mark Egerton who retires after 18 years as CEO with Quotient Sciences. As part of...
Learn moreQuotient Sciences, a leading global pharmaceutical drug development and manufacturing accelerator, is proud to announce the successful completion of a US Food and Drug Administration (FDA) inspection of its bioanalytical facility in Alnwick...
Learn more
